We all want good quality in health care and to see quality regularly improving. But many issues have been raised about either the development or application of various quality measures. An article in the Journal of the American Medical Association examines a measure regarding prevention of venous thromboembolism and finds that surveillance bias undermines the utility of the measure. (JAMA Article) Surveillance bias exists when variation in scores or results is due variation in screening or looking for the thing to be measured. In this example, a hospital that is more aggressive in looking for and identifying potential VTE cases, will likely find more and therefore end up with a worse score on the quality measure. Paradoxically, a hospital that didn’t look at all might have fewer cases and a better score, but would clearly be delivering worse care to its patients. The researchers’ analysis included a general quality measure for the hospital, rates of VTE prophylaxis and hospital risk-adjusted VTE rates. Medicare data was the primary information source. Overall hospitals have high compliance with VTE prophylaxis, around 94.5%. As might be expected, hospitals with a higher general quality measure had higher VTE prophylaxis rates. But those with higher prophylaxis rates also had higher VTE event rates. There was an unexpected association between supposed higher quality and worse outcomes. But the higher quality hospitals also had much higher rates of VTE imaging studies, suggesting that they were simply finding more VTEs, not that they actually had more than the lower-quality hospitals. The results should cause policymakers to stop using this quality measure, as it may actually encourage hospital to provide worse care by not looking for VTEs that they then have to report.
✅ Subscribe via Email
About this Blog
The Healthy Skeptic is a website about the health care system, and is written by Kevin Roche, who has many years of experience working in the health industry. Mr. Roche is available to assist health care companies through consulting arrangements through Roche Consulting, LLC and may be reached at [email protected].
Healthy Skeptic Podcast
This is an outstanding report on total global drug spending and trends, with projections out to 2025. It helps you understand this important area of health care, which does much...
June 1, 2021
MedPAC 2019 Report to Congress
June 18, 2019
A lot of money is invested in health care startups and growth companies, since health care is 20% of the economy, but the returns aren’t always good. Here is another...
November 1, 2022
HealthJoy delights investors by garnering $60 million in mindless new capital to support its benefits navigation tool. Another sign of too much capital still floating around out there.
November 1, 2022
It may be investors that need the redesign. They just keep pouring money into this digital health crap despite all the losses. Redesign Health claims that it makes money by...
September 16, 2022
Access ACO Care Management Chronic Disease Comparative Effectiveness Consumer Directed Health Consumers Devices Disease Management Drugs EHRs Elder Care End-of-Life Care FDA Financings Genomics Government Health Care Costs Health Care Quality Health Care Reform Health Insurance Health Insurance Exchange HIT HomeCare Hospital Hospital Readmissions Legislation M&A Malpractice Meaningful Use Medicaid Medical Care Medicare Medicare Advantage Mobile Pay For Performance Pharmaceutical Physicians Providers Regulation Repealing Reform Telehealth Telemedicine Wellness and Prevention Workplace